David N Adler

434 total citations
4 papers, 352 citations indexed

About

David N Adler is a scholar working on Molecular Biology, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, David N Adler has authored 4 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Psychiatry and Mental health and 1 paper in Pharmacology. Recurrent topics in David N Adler's work include Schizophrenia research and treatment (2 papers), Cholinesterase and Neurodegenerative Diseases (1 paper) and Treatment of Major Depression (1 paper). David N Adler is often cited by papers focused on Schizophrenia research and treatment (2 papers), Cholinesterase and Neurodegenerative Diseases (1 paper) and Treatment of Major Depression (1 paper). David N Adler collaborates with scholars based in United States. David N Adler's co-authors include Joseph I. Friedman, Kenneth L. Davis, Leonard White, Philip D. Harvey, Michael Parrella, Evelyn Howanitz, Susan R. McGurk, Tenko Raykov, Nicholas D. Tsopelas and Wei‐Yann Tsai and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

David N Adler

4 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David N Adler United States	4	200	103	99	86	81	4	352
Céline Goldberger France	9	145 0.7×	74 0.7×	59 0.6×	70 0.8×	66 0.8×	19	335
Eriene Youssef United States	5	236 1.2×	128 1.2×	116 1.2×	168 2.0×	36 0.4×	5	469
Hugh Jones United Kingdom	13	367 1.8×	108 1.0×	39 0.4×	192 2.2×	52 0.6×	19	501
Jérôme Lerond France	7	97 0.5×	94 0.9×	60 0.6×	89 1.0×	22 0.3×	8	328
M. Blanaru Israel	8	128 0.6×	167 1.6×	112 1.1×	91 1.1×	94 1.2×	12	494
E. Wezenberg Netherlands	7	79 0.4×	87 0.8×	61 0.6×	134 1.6×	75 0.9×	11	300
S. Franco Canada	10	211 1.1×	159 1.5×	61 0.6×	237 2.8×	24 0.3×	14	458
D Bobon Belgium	10	131 0.7×	35 0.3×	68 0.7×	30 0.3×	76 0.9×	38	300
Sylvie Chouinard Canada	9	149 0.7×	66 0.6×	65 0.7×	254 3.0×	52 0.6×	14	431
D Bente Germany	10	165 0.8×	102 1.0×	65 0.7×	94 1.1×	65 0.8×	58	387

Countries citing papers authored by David N Adler

Since Specialization

Citations

This map shows the geographic impact of David N Adler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David N Adler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David N Adler more than expected).

Fields of papers citing papers by David N Adler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David N Adler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David N Adler. The network helps show where David N Adler may publish in the future.

Co-authorship network of co-authors of David N Adler

This figure shows the co-authorship network connecting the top 25 collaborators of David N Adler. A scholar is included among the top collaborators of David N Adler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David N Adler. David N Adler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Friedman, Joseph I., Jean-Pierre Lindenmayer, Leonard White, et al.. (2011). Pimozide Augmentation of Clozapine Inpatients with Schizophrenia and Schizoaffective Disorder Unresponsive to Clozapine Monotherapy. Neuropsychopharmacology. 36(6). 1289–1295. 23 indexed citations

2.

Friedman, Joseph I., David N Adler, Evelyn Howanitz, et al.. (2002). A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia. Biological Psychiatry. 51(5). 349–357. 140 indexed citations

3.

Friedman, Joseph I., Philip D. Harvey, Susan R. McGurk, et al.. (2002). Correlates of Change in Functional Status of Institutionalized Geriatric Schizophrenic Patients: Focus on Medical Comorbidity. American Journal of Psychiatry. 159(8). 1388–1394. 61 indexed citations

4.

Friedman, Joseph I., David N Adler, & Kenneth L. Davis. (1999). The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biological Psychiatry. 46(9). 1243–1252. 128 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact